Clinical Trial Update: Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis [NA]

View source ↗

Summary

The update discusses a clinical trial investigating blockade of the angiotensin II receptor with losartan in patients with lupus nephritis. The phase and curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Lupus Nephritis

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Atherosclerosis, Lupus Nephritis | NA | Status: UNKNOWN